Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome

Zollinger Ellison Syndrome Clinical Trial

Official title:
Evaluation of the Gastrinoma in Patients With Zollinger-Ellison Syndrome

Status Completed

Clinical Trial Summary

This protocol concerns the approach to the localization, diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the subsequent management of the tumor and tissue samples for research.

Clinical Trial Description

This protocol concerns the approach to the localization and management of the tumor in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00001254
Study type	Observational
Source	National Institutes of Health Clinical Center (CC)
Contact
Status	Completed
Phase
Start date	October 29, 1991

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00001165` - Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas	Phase 2
Completed	`NCT00001228` - Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer	Phase 2
Completed	`NCT00001241` - Treatment of Zollinger-Ellison Syndrome	N/A
Completed	`NCT00001240` - Evaluating Patients With Abnormal Levels of Gastric Acid	N/A
Completed	`NCT00001191` - The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid	Phase 2
Withdrawn	`NCT02831179` - Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor	Phase 1